News

Alchemab Therapeutics unveils Alzheimer’s candidate ATLX-1088 targeting CD33 at the Antibody Industrial Symposium

by

CAMBRIDGE, England, June 22, 2023 /PRNewswire/ — Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that it unveiled data on ATLX-1088, its newly-discovered preclinical Alzheimer’s candidate, at the Antibody Industrial Symposium in Tours, France, 22-23 June 2023. ATLX-1088 is a potential first-in-class human antibody targeting CD33, … Read more

Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry

by

TOKYO, June 22, 2023 /PRNewswire/ — The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications. The company will supply materials to all global regions, including Asia such as China, India, Europe, and the U.S. Image:https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202306166403/_prw_PI1lg_ZBGJFiCu.jpeg In the medical device marketplace, manufacturers and end … Read more

Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for Medical Industry

by

TOKYO, June 22, 2023 /PRNewswire/ — The Polyplastics Group is pleased to announce the commercial availability of its DURACON (R) POM (Polyoxymethylene/Acetal) PM Series for medical applications. The company will supply materials to all global regions, including Asia such as China, India, Europe, and the U.S. Image:https://cdn.kyodonewsprwire.jp/prwfile/release/M100475/202306166403/_prw_PI1lg_ZBGJFiCu.jpeg In the medical device marketplace, manufacturers and end … Read more

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

by

Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures Unique Click-to-Release platform enables on-target activation of antibody-drug conjugates (ADCs) and immunomodulators, as well as off-target deactivation of radiopharmaceuticals Proceeds will be used to advance the lead program, a click-cleavable ADC targeting TAG72, into … Read more

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics

by

Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures Unique Click-to-Release platform enables on-target activation of antibody-drug conjugates (ADCs) and immunomodulators, as well as off-target deactivation of radiopharmaceuticals Proceeds will be used to advance the lead program, a click-cleavable ADC targeting TAG72, into … Read more

Yinfei Yin rejoint Shanghai ChemPartner en tant que vice-président et chef de la biologie et de la pharmacologie

by

SHANGHAI, 22 juin 2023 /PRNewswire/ — ChemPartner a annoncé aujourd’hui la nomination de Yinfei Yin, titulaire d’un doctorat en oncologie, au poste de vice-président et chef du département de biologie et de pharmacologie à Shanghai ChemPartner. M. Yin apporte une riche expérience et une vaste expertise à son nouveau poste, puisqu’il s’est imposé comme un scientifique hautement … Read more

Kinetic Insights with AssayQuant’s Fully Automated KinSight™ Kinome Profiling Services

by

MARLBOROUGH, Mass., June 21, 2023 /PRNewswire/ — AssayQuant® Technologies, Inc. introduces KinSight™ Kinome Profiling Services providing superior results including kinetic insights into selectivity and mechanisms of action for drug discovery. Kinase inhibitors are effective in targeting deregulation mechanisms that drive disease progression, yet only 15% of kinases have FDA-approved inhibitors. AssayQuant’s kinome profiling platform provides … Read more

Innovative Radiopharmaceuticals to Boost Cardiac Applications

by

DUBLIN, June 21, 2023 /PRNewswire/ — The “Mannequin-Based Simulation: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Mannequin-Based Simulation estimated at US$1.7 Billion in the year 2022, is projected to reach a revised size of US$5.6 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. … Read more

Innovative Radiopharmaceuticals to Boost Cardiac Applications

by

Dublin, June 21, 2023 /PRNewswire/ — The “Radiopharmaceuticals: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering. The global market for Radiopharmaceuticals estimated at US$6.3 Billion in the year 2022, is projected to reach a revised size of US$12.6 Billion by 2030, growing at a CAGR of 9.1% over the analysis period 2022-2030. SPECT Radioisotopes, … Read more